Osaic Holdings
AXSM icon

Osaic Holdings’s Axsome Therapeutics AXSM Stock Holding History

Osaic Holdings’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1
Closed -$2.38K – 7410
2024
Q3 		$2.38K Hold
1
– – ﹤0.01% 6544
2024
Q2 		$1.79K Hold
1
– – ﹤0.01% 6641
2024
Q1 		$2.04K Hold
1
– – ﹤0.01% 6462
2023
Q4 		$2.26K Hold
1
– – ﹤0.01% 6497
2023
Q3 		$1.8K Hold
1
– – ﹤0.01% 6666
2023
Q2 		$2.18K Buy
+1
New +$74 ﹤0.01% 6633

Other funds holding AXSM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Osaic Holdings's AXSM Position: Q1 2026 in Review

Osaic Holdings reduced its Axsome Therapeutics (AXSM) stake by 69% in Q1 2026, selling an estimated $2.1M and leaving 5,468 shares worth $924K. The position accounts for ﹤0.01% of the portfolio, ranked #2785.

Osaic Holdings first reported a position in AXSM in Q1 2020 and has held it in 25 quarters since. The position peaked at $3.22M in Q4 2025. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

  • Osaic Holdings held 5,468 shares of Axsome Therapeutics worth $924K as of Q1 2026.
  • Osaic Holdings sold 12,174 Axsome Therapeutics shares in Q1 2026, an estimated $2.1M.
  • Axsome Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #2785 holding.
  • Osaic Holdings first reported a position in Axsome Therapeutics in Q1 2020 and has held it in 25 quarters since.
  • Osaic Holdings's Axsome Therapeutics position peaked at $3.22M in Q4 2025.
  • 409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.